Navigation Links
Dendreon Reports Third Quarter 2010 Financial Results
Date:11/3/2010

y dialing 1-888-286-8010 or +1-617-801-6888 for international callers; the conference ID number is 97336729. The replay will be available from 7:30 p.m. ET on Wednesday, November 3rd until 11:59 p.m. ET on Wednesday, November 10th. In addition, the webcast will be archived for on-demand listening for 30 days at www.dendreon.com.

About DendreonDendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development, commercialization and manufacturing of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response in a variety of tumor types. Dendreon’s first product, PROVENGE®, was approved by the FDA in April 2010. Dendreon is exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. The Company is headquartered in Seattle, Washington and is traded on the NASDAQ Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com/.

This news release contains forward-looking statements that are subject to risks and uncertainties. Factors that could affect these forward-looking statements include, but are not limited to, developments affecting Dendreon's business and prospects, including progress on the commercialization efforts for PROVENGE.  Information on the factors and risks that could affect Dendreon's business, financial condition and results of operations are contained in Dendreon's public disclosure filings with the U.S. Securities and Exchange Commission, which are available at www.sec.gov. Dendreon cautions investors not
'/>"/>

SOURCE Dendreon Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Presentation of PROVENGE Data at the 25th International Society for Biological Therapy of Cancer Annual Meeting
2. Dendreon Statement on CMS National Coverage Analysis
3. Dendreon Announces Presentation of PROVENGE Data at the American Urological Association Annual Meeting
4. Dendreon Presents Updated IMPACT Results Confirming PROVENGE Improves Overall Survival in Patients With Metastatic Castrate-Resistant Prostate Cancer
5. Dendreon Reports Fourth Quarter and 2009 Year End Financial Results
6. Dendreon Announces Election of Ian Clark and Pedro Granadillo to Board of Directors
7. Dendreon Reports PROVENGE Regulatory and Commercialization Progress and Future Pipeline Plans at Analyst Event
8. Dendreon Presents Preclinical Data Demonstrating Activity of TRPM8 Agonist, D-3263, in Benign Prostatic Hyperplasia
9. Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
10. Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial
11. Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... July 30, 2015 Tissue ... the regenerative medical devices company, announces that it ... wound care market as Tissue Regenix Wound Care ... Medicare administrator, First Coast Service Options Inc. ("First ... , Puerto Rico and ...
(Date:7/29/2015)... , July 30, ... Guidance   ... including Core Earnings and ... Highlights of Q1 results  ... Underlying core earnings and underlying core EPS were flat, year-to-year , ...
(Date:7/29/2015)... -- Insulet Corporation (NASDAQ: PODD ), the leader ... Insulin Management System, today announced preliminary revenue results ... Company also announced that it will postpone the full ... call from Thursday, July 30, as originally scheduled.   ... , Preliminary second quarter revenue results: ...
Breaking Medicine Technology:Tissue Regenix Group plc: First Coast Service Options Inc. Approves Medicare Coverage for DermaPure 2Tissue Regenix Group plc: First Coast Service Options Inc. Approves Medicare Coverage for DermaPure 3Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 2Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 3Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 4Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 5Insulet Reports Preliminary Second Quarter 2015 Revenue Results 2Insulet Reports Preliminary Second Quarter 2015 Revenue Results 3Insulet Reports Preliminary Second Quarter 2015 Revenue Results 4Insulet Reports Preliminary Second Quarter 2015 Revenue Results 5
... LONDON, March 19, 2007-AstraZeneca today announced that ... results from the ARISE (Aggressive Reduction of ... which studied,AGI-1067, an investigational anti-atherosclerotic agent with,antioxidant ... disease (CAD). ,The ARISE trial did not ...
... /PRNewswire-FirstCall/ --,Nuvelo, Inc. today announced that clinical data ... MACE)/TIMI 32 Phase,2 trial looking at recombinant nematode ... coronary syndromes,(NSTE-ACS) will be presented in a V-poster ... Session taking place in New,Orleans, LA, March 24-27, ...
Cached Medicine Technology:Coronary Artery Disease ARISE Trial Showed AGI-1067 Did Not Meet,Primary Endpoint 2Nuvelo Announces Presentation on rNAPc2 at American College of,Cardiology 56th Annual Scientific Session 2Nuvelo Announces Presentation on rNAPc2 at American College of,Cardiology 56th Annual Scientific Session 3
(Date:7/30/2015)... , ... July 30, 2015 , ... Quintessa Medical Spa ... is a nonsurgical treatment designed specifically for the elimination of excess tissue ... the first locations in the state of Wisconsin to offer this innovative treatment. , ...
(Date:7/30/2015)... , ... July 30, 2015 , ... Gummy smile ... lip lowering, gum contouring and surgery, as well as the patented gum depigmentation treatmet. ... has made him popular with many patients from around the world. , “Like treatment ...
(Date:7/30/2015)... , ... July 30, 2015 , ... ... entity on behalf of the New Jersey Department of Health, has received a ... Technology, an agency of the U.S. Department of Health and Human Services (HHS). ...
(Date:7/30/2015)... ... ... New research finds some distinct differences in the way mesothelioma behaves in younger ... website. , Researchers with the National Institutes of Health, the FDA, and the ... between 1990 and 2010. Two percent of these cases (207) occurred in people younger ...
(Date:7/30/2015)... ... , ... Bird B Gone, the leader in bird control products for commercial, ... pest birds from the AC units and ventilation systems on hospital roofs. Bird droppings ... West Nile virus. When these droppings dry, the fine powder can be carried into ...
Breaking Medicine News(10 mins):Health News:Quintessa MedSpa Offers Nonsurgical Double-chin Elimination 2Health News:Gummy Smile Dentist, Alex Farnoosh DMD, is Now Offering Comprehensive Treatment Options for Gummy Smiles 2Health News:New Jersey Innovation Institute Awarded $2.9 Million Federal Grant to Advance Health Information Technology Services to Support Health Information Exchange 2Health News:Study Finds Mesothelioma Behaves Differently in Younger People, According to Surviving Mesothelioma 2Health News:Bird B Gone’s New Bird Hazing System Keeps Disease-Carrying Bird Droppings Out of Hospitals 2
... ... for Healthcare Professionals. , ... Bristol, TN (PRWEB) February 3, 2010 -- King Pharmaceuticals, Inc. ... tools, and essential resources to healthcare professionals and others, helping them provide optimal, ...
... ... American Heart Association’s “Go Red for Women” event in Denver, Colorado. , ... Independence, OH (PRWeb) February 3, ... Red for Women” event in Denver, Colorado. The “Speak Up To Save Lives” ...
... , ... to help healthcare professionals with health literacy solutions for the 90 million literacy challenged ... ... for Healthcare Advancement (IHA), a not-for-profit healthcare organization and a national leader in health ...
... ... In this day and age of specialization and compartmentalization, liberal arts and ... study. For individuals who desire a well-rounded, more classical education, a ... subjects can range from communications and journalism to general arts and the ...
... WASHINGTON , Feb. 2 Sanford Wittels ... announced today that AtriCure, Inc., a medical device company specializing in ... Department of Justice (DOJ) and the Office of the Inspector General ... million plus interest over a five-year period. Sanford Wittels ...
... better, study found , TUESDAY, Feb. 2 (HealthDay News) -- ... will be able to kick the habit and reduces the ... found. , The study included 568 adults who smoked 10 ... year. The smokers who used nicotine patches for the entire ...
Cached Medicine News:Health News:King Launches Painbalance: Educational Initiative to Help Reduce the Burden of Pain 2Health News:King Launches Painbalance: Educational Initiative to Help Reduce the Burden of Pain 3Health News:King Launches Painbalance: Educational Initiative to Help Reduce the Burden of Pain 4Health News:Life Line Screening Supports the American Heart Association's 'Go Red for Women' Event in Denver, Colorado 2Health News:Institute for Healthcare Advancement's Ninth Annual Health Literacy Conference Set for May 6-7, 2010 in Irvine, Calif. 2Health News:Institute for Healthcare Advancement's Ninth Annual Health Literacy Conference Set for May 6-7, 2010 in Irvine, Calif. 3Health News:OnlineEducation.com Announces Expansion of Liberal Arts & Humanities to its Accredited Online Degree Programs 2Health News:OnlineEducation.com Announces Expansion of Liberal Arts & Humanities to its Accredited Online Degree Programs 3Health News:OnlineEducation.com Announces Expansion of Liberal Arts & Humanities to its Accredited Online Degree Programs 4Health News:Relator's Attorneys Comment on AtriCure/DOJ Settlement 2Health News:Relator's Attorneys Comment on AtriCure/DOJ Settlement 3Health News:Using Nicotine Patch Longer Boosts Efforts to Quit 2
... new Oculus Easygraph is a corneal ... tools you need for refractive surgery, ... therapy contact lens fitting in a ... 4" package. All you need to ...
The only ergonomic work station of its kind with an optional built-in keratograph and flat-screen. The Concepta is a modern workstation for the examination and refraction of patients....
The natural look of 3 in 1 technology in virtually any prescription....
Dot matrix pattern for light eyed patients....
Medicine Products: